Walleye Capital LLC Ionis Pharmaceuticals Inc Put Options Transaction History

Walleye Capital LLC

12 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$40.06 - $51.86 $1.25 Million - $1.62 Million	-31,200 Reduced 82.98%	6,400 $256,000
Q2 2024 Aug 14, 2024	BUY	$36.45 - $47.7 $1.25 Million - $1.64 Million	34,300 Added 1039.39%	37,600 $1.79 Million
Q1 2024 May 15, 2024	SELL	$42.03 - $53.55 $222,759 - $283,815	-5,300 Reduced 61.63%	3,300 $143,000
Q4 2023 Feb 14, 2024	SELL	$43.39 - $51.63 $564,070 - $671,190	-13,000 Reduced 60.19%	8,600 $435,000
Q3 2023 Nov 14, 2023	SELL	$38.5 - $47.13 $311,850 - $381,753	-8,100 Reduced 27.27%	21,600 $979,000
Q2 2023 Aug 14, 2023	BUY	$34.73 - $43.33 $340,353 - $424,634	9,800 Added 49.25%	29,700 $1.22 Million
Q1 2023 May 15, 2023	BUY	$33.58 - $41.2 $668,242 - $819,880	19,900 New	19,900 $711,000
Q1 2020 May 15, 2020	SELL	$41.6 - $63.4 $4,160 - $6,340	-100 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$53.85 - $65.27 $43,080 - $52,216	-800 Reduced 88.89%	100 $6,000
Q3 2019 Nov 14, 2019	SELL	$59.06 - $72.15 $124,026 - $151,515	-2,100 Reduced 70.0%	900 $54,000
Q2 2019 Aug 14, 2019	BUY	$62.09 - $86.14 $149,016 - $206,736	2,400 Added 400.0%	3,000 $193,000
Q1 2019 May 15, 2019	BUY	$52.92 - $81.17 $31,752 - $48,702	600 New	600 $49,000

402

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.83B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.